image: Addressing the latest advances at the intersection of postgenomics medicine, biotechnology and global society, including the integration of multi-omics knowledge, data analyses and modeling, and applications of high-throughput approaches to study complex biological and societal problems. view more
Credit: Mary Ann Liebert, Inc., publishers
New Rochelle, NY, May 13, 2020--Artificial intelligence, machine learning, blockchain, and other key digital technology applications will play a vital role addressing the new healthcare challenges triggered by the COVID-19 pandemic, according to a peer-reviewed Special Issue of OMICS: A Journal of Integrative Biology. Click here to read the Special Issue free on the OMICS website through June 13, 2020.
"COVID-19 is undoubtedly among the ecological determinants of planetary health," states Vural Özdemir, MD, PhD, Editor-in-Chief of OMICS in his editorial. "Digital health is a veritable opportunity for integrative biology and systems medicine to broaden its scope from human biology to ecological determinants of health," he said. "This is very important."
Despite a widespread belief that media coverage of artificial intelligence tends to be negative, Colin Garvey and Chandler Maskal, Rensselaer Polytechnic Institute (Troy, NY) report that the majority of the news coverage is positive. Click here to read the article.
###
Other articles in the special issue include an interview on "Responsible Innovation and Future Science in Australia," by Justine Lacey, Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia, and Erik Fisher, Arizona State University, Tempe, new research articles, and expert reviews such as "Blockchain for Digital Health: Prospects and Challenges" and "Integrating Artificial and Human Intelligence: A Partnership for Responsible Innovation in Biomedical Engineering and Medicine."
About the Journal
OMICS: A Journal of Integrative Biology is an authoritative and highly innovative peer-reviewed interdisciplinary journal published monthly online, addressing the latest advances at the intersection of postgenomics medicine, biotechnology and global society, including the integration of multi-omics knowledge, data analyses and modeling, and applications of high-throughput approaches to study complex biological and societal problems. Public policy, governance and societal aspects of the large-scale biology and 21st century data-enabled sciences are also peer-reviewed. Complete tables of content and a sample issue may be viewed on the OMICS: A Journal of Integrative Biology website.
About the Publisher
Mary Ann Liebert, Inc., publishers is known for establishing authoritative peer-reviewed journals in many areas of science and biomedical research. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN) was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 90 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.